Clinical Research
Copyright ©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 1144-1148
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1144
Table 1 Feces examination of Cyclospore cayetanensis in different groups (n,%)
GroupnAuramine-phenol stain + Modified acid-fast stain
Positive numberPositive rate
Control groupb40010.25
Infants20000.00
Pupils20010.50
Experimental groupb210136.19
Diarrheal patients178105.62
Immnocompromised individuals3239.38
Total610142.30
Table 2 Clinical symptoms caused by Cyclospore cayetanensis (n,%)
GroupCase numberCase Percentage
Non-self-conscious symptom428.57
Self-conscious symptom1071.43
General symptom214.29
Upper digestive tract symptom17.14
Lower digestive tract symptom428.57
Upper and lower17.14
digestive tract symptom
General and upper17.14
digestive tract symptom
General and upper, lower17.14
digestive tract symptom
Total14100
Table 3 Feces examination of Cyclospore cayetanensis of differ-ent gender
GroupnAuramine-phenol stain+Modified anti-acid stain
Positive numberPositive rate (%)
Male383102.61
Female22741.44
Total610142.30
Table 4 Feces examination of Cyclospore cayetanensi in differ-ent areas
GroupnAuramine-phenol stain+Modified acid-fast stain
Positive numberPositive rate (%)
Urban area32530.92
Rural area285113.86
Total610142.30
Table 5 Detection of specific antibody of individuals with Cyclospore cayetanensis (n,%)
GroupnIgGb
IgMb
IgG+IgMb
NumberRateNumberRateNumberRate
Oocysts positive14963.41117.07419.51
Oocysts negative2000.0000.0000.00
Table 6 Detection of T lymphocyte cell subsets of individuals with Cyclospore cayetanensis (n, -x±s,%)
GroupnCD3+CD4+CD8+CD4+/CD8+
Oocysts positive1464.28 ± 6.55a43.55 ± 5.80c28.23 ± 4.321.52 ± 0.32b
Oocysts negative2058.97 ± 5.2339.26 ± 4.9330.54 ± 5.171.26 ± 0.21